secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bolt Biotherapeutics, Inc. (BOLT)
CIK:        0001641281
Form:       8-K
Filed at:   2024-12-23T23:59:59+00:00
Accession:  0000950170-24-139580
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Director Mahendra Shah resigns from Bolt Biotherapeutics board; Dupont added to two committees
--------------------------------------------------------------------------------

- Dr. Mahendra Shah notified his resignation on Dec 19, effective Dec 31, 2024, for personal reasons.
- Shah's departure not due to any disagreement with the company's operations, policies, or practices.
- Board appointed existing director Dr. Jakob Dupont to the Audit Committee and Nominating and Corporate Governance Committee, effective upon Shah's resignation.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1641281/000095017024139580/0000950170-24-139580-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1641281/000095017024139580/bolt-20241223.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-139580

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer